JP2013505255A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505255A5
JP2013505255A5 JP2012529909A JP2012529909A JP2013505255A5 JP 2013505255 A5 JP2013505255 A5 JP 2013505255A5 JP 2012529909 A JP2012529909 A JP 2012529909A JP 2012529909 A JP2012529909 A JP 2012529909A JP 2013505255 A5 JP2013505255 A5 JP 2013505255A5
Authority
JP
Japan
Prior art keywords
digestive enzyme
multiparticulate
coating
enzyme composition
lipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012529909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505255A (ja
JP5877399B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049203 external-priority patent/WO2011035079A1/en
Publication of JP2013505255A publication Critical patent/JP2013505255A/ja
Publication of JP2013505255A5 publication Critical patent/JP2013505255A5/ja
Application granted granted Critical
Publication of JP5877399B2 publication Critical patent/JP5877399B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012529909A 2009-09-17 2010-09-17 膵炎及び膵不全を治療するための膵酵素組成物及び方法 Expired - Fee Related JP5877399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24346709P 2009-09-17 2009-09-17
US61/243,467 2009-09-17
PCT/US2010/049203 WO2011035079A1 (en) 2009-09-17 2010-09-17 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency

Publications (3)

Publication Number Publication Date
JP2013505255A JP2013505255A (ja) 2013-02-14
JP2013505255A5 true JP2013505255A5 (cg-RX-API-DMAC7.html) 2013-11-07
JP5877399B2 JP5877399B2 (ja) 2016-03-08

Family

ID=43730817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529909A Expired - Fee Related JP5877399B2 (ja) 2009-09-17 2010-09-17 膵炎及び膵不全を治療するための膵酵素組成物及び方法

Country Status (23)

Country Link
US (2) US8784884B2 (cg-RX-API-DMAC7.html)
EP (1) EP2477645B1 (cg-RX-API-DMAC7.html)
JP (1) JP5877399B2 (cg-RX-API-DMAC7.html)
KR (1) KR101771752B1 (cg-RX-API-DMAC7.html)
CN (2) CN105214073A (cg-RX-API-DMAC7.html)
AR (1) AR078291A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010295494B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012005837A8 (cg-RX-API-DMAC7.html)
CA (1) CA2774269C (cg-RX-API-DMAC7.html)
CL (1) CL2012000658A1 (cg-RX-API-DMAC7.html)
CO (1) CO6531419A2 (cg-RX-API-DMAC7.html)
ES (1) ES2690661T3 (cg-RX-API-DMAC7.html)
HK (1) HK1218886A1 (cg-RX-API-DMAC7.html)
IL (2) IL218656A (cg-RX-API-DMAC7.html)
MX (1) MX2012003214A (cg-RX-API-DMAC7.html)
MY (1) MY161843A (cg-RX-API-DMAC7.html)
NZ (1) NZ599143A (cg-RX-API-DMAC7.html)
RU (1) RU2570376C2 (cg-RX-API-DMAC7.html)
SA (1) SA110310695B1 (cg-RX-API-DMAC7.html)
TW (2) TW201639545A (cg-RX-API-DMAC7.html)
UY (1) UY32896A (cg-RX-API-DMAC7.html)
WO (1) WO2011035079A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201202761B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
CN101686943B (zh) 2007-02-20 2014-03-26 阿普塔利斯制药有限公司 稳定的消化酶组合物
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
EP2818160B1 (en) * 2010-10-01 2017-11-08 Aptalis Pharma Limited Enteric coated, low-strength pancrelipase formulations
KR101953413B1 (ko) 2011-08-08 2019-02-28 앨러간 파마슈티컬스 인터내셔널 리미티드 소화효소들을 함유하는 고형 조성물들의 용해 시험 방법
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
WO2015193730A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
FR3079146B1 (fr) * 2018-03-23 2020-04-17 Karim Ioualalen Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive.
WO2021202363A1 (en) * 2020-03-30 2021-10-07 Wall Jai Combined animal-derived and synthetically produced pancreatic enzyme replacement therapy

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
US5578304A (en) 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5260074A (en) 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5460812A (en) 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5302400A (en) 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
EP0879048B2 (en) 1996-02-09 2009-07-29 Quadrant Drug Delivery Limited Method for making tablets using trehalose
US5750104A (en) 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
CN1156308C (zh) * 2002-04-19 2004-07-07 北京世诺医药科技有限公司 多酶组合胶囊
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
EP1596838A2 (en) 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
AU2004285558A1 (en) 2003-10-29 2005-05-12 Altus Pharmaceuticals Inc. Non-pancreatic proteases for controlling plasma cholecystokinin (CCK) concentration and for treating pain
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US7470435B2 (en) 2003-11-17 2008-12-30 Andrx Pharmaceuticals, Llc Extended release venlafaxine formulation
RU2381813C2 (ru) 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
WO2005115445A1 (en) * 2004-05-24 2005-12-08 Novozymes A/S Enzymes for pharmaceutical use
DE602005022471D1 (de) * 2004-10-14 2010-09-02 Altus Pharmaceuticals Inc Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
MX2007015472A (es) * 2005-06-24 2008-04-17 Novozymes As Lipasas para uso farmaceutico.
US20070025977A1 (en) 2005-07-21 2007-02-01 Mulberg Andrew E Method of treating steatorrhea in infants
CA2616943C (en) 2005-07-29 2016-04-12 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
MX2008015031A (es) * 2006-05-26 2008-12-05 Nestec Sa Metodos de uso y composiciones nutritivas de extracto de touchi.
US20080199448A1 (en) * 2007-02-16 2008-08-21 Ross Mairi R Enzyme composition for improving food digestion
CN101686943B (zh) 2007-02-20 2014-03-26 阿普塔利斯制药有限公司 稳定的消化酶组合物
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
EP2328566A1 (en) 2008-09-30 2011-06-08 DSM IP Assets B.V. Enzyme composition and application thereof in the treatment of pancreatic insufficiency

Similar Documents

Publication Publication Date Title
JP2013505255A5 (cg-RX-API-DMAC7.html)
MX2013003627A (es) Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia.
RU2012113253A (ru) Композиции панкреатических ферментов и способы лечения панкреатита и недостаточности поджелудочной железы
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
ZA200807778B (en) Reverse-Phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations WDG-CS, ZC, EC-SC and CX
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
IN2014MN00139A (cg-RX-API-DMAC7.html)
KR20090122254A (ko) 안정한 소화 효소 조성물
WO2012013331A3 (en) Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
JP2015523321A5 (cg-RX-API-DMAC7.html)
WO2011139044A3 (ko) 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
NZ700824A (en) Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
JP2016530279A5 (cg-RX-API-DMAC7.html)
WO2012067481A3 (es) Composición farmacéutica de administración oral para el tratamiento del síndrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retención de gases y enzimas digestivas y proceso para su preparación
WO2008031835A3 (en) Method of treating autoimmune diseases using vegf-pathway inhibitors
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
GEP20156386B (en) New crystal form vii of agomelatine, preparation method and usage thereof, and pharmaceutical compositions containing thereof
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2012063005A3 (fr) Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
WO2013098268A3 (en) Tablets and dry-coated agents
WO2012067482A3 (es) COMPOSICIÓN FARMACÉUTICA ADAPTADA PARA ADMINISTRARSE ORALMENTE Y PROCESO PARA SU PREPARACIÓN, PARA PREVENCIÓN Y TRATAMIENTO DEL SÍNDROME DE INTESTINO IRRITABLE, A BASE DE UN MODIFICADOR DE LA MOTILIDAD INTESTINAL Y α-D-GALAGTOSIDASA
JP2012041314A5 (cg-RX-API-DMAC7.html)
NZ597957A (en) Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
WO2024050289A1 (en) Compositions for oral delivery
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone